Laurion Capital Management LP Sarepta Therapeutics, Inc. Call Options Transaction History

Laurion Capital Management LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 May 08, 2019	SELL	$106.67 - $151.68 $117,337 - $166,848	-1,100 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $3.16 Million - $4.83 Million	-32,500 Reduced 96.73%	1,100 $120,000
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $3.87 Million - $5.43 Million	33,600 New	33,600 $5.43 Million
Q4 2017 Feb 13, 2018	SELL	$47.64 - $56.75 $7.33 Million - $8.73 Million	-153,900 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$35.73 - $47.15 $5.5 Million - $7.26 Million	153,900	153,900 $6.98 Million

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.